Nutex Health (NASDAQ:NUTX) Shares Up 5.9% - Should You Buy?

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) was up 5.9% during trading on Thursday . The stock traded as high as $127.95 and last traded at $127.95. Approximately 72,016 shares changed hands during trading, a decline of 5% from the average daily volume of 75,415 shares. The stock had previously closed at $120.77.

Analyst Upgrades and Downgrades

NUTX has been the topic of several research analyst reports. Wall Street Zen lowered Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd. Benchmark upped their price objective on Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research note on Thursday, May 15th. Finally, Maxim Group upped their price objective on Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th.

Nutex Health Stock Performance

The stock has a 50 day simple moving average of $137.12 and a 200 day simple moving average of $77.90. The stock has a market cap of $679.27 million, a P/E ratio of -13.03 and a beta of 0.04. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $2.71. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The firm had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million.

Insiders Place Their Bets

In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of the stock in a transaction dated Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, with a total value of $81,810.00. Following the transaction, the chief financial officer now owns 4,888 shares in the company, valued at approximately $399,887.28. The trade was a 25.72% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 36.92% of the company's stock.

Institutional Trading of Nutex Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bank of America Corp DE increased its position in Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares in the last quarter. Northern Trust Corp acquired a new position in Nutex Health during the 4th quarter valued at about $200,000. Millennium Management LLC acquired a new position in Nutex Health during the 4th quarter valued at about $213,000. World Investment Advisors acquired a new position in Nutex Health during the 4th quarter valued at about $217,000. Finally, OMERS ADMINISTRATION Corp acquired a new position in Nutex Health during the 4th quarter valued at about $231,000. 5.32% of the stock is owned by institutional investors.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.